Karyopharm to Present at 40th Annual J.P. Morgan Healthcare Conference
- Tuesday, January 4, 2022, 7:00
- Finance
- Add a comment
NEWTON, Mass., Jan. 4, 2022 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that Richard Paulson, President and Chief Executive Officer of Karyopharm, will present at the 40th Annual J….